Corcept Therapeutics (CORT) Net Margin (2012 - 2026)
Corcept Therapeutics (CORT) posted Net Margin of 36.56% for Q3 2026, up 27.24 percentage points from 9.32% a year earlier and up 20.11 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Net Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Margin at Corcept Therapeutics was 16.53%, up 2.42 percentage points year-over-year; for FY2025, it came in at 12.89%, down 7.81 percentage points from FY2024.
- Annual Net Margin has declined for four consecutive years, with a five-year change of -17.06 percentage points (FY2020 to FY2025).
- In prior years, Corcept Therapeutics' Net Margin was 20.70% in FY2024 (-1.17 pp), 21.87% in FY2023 (-3.33 pp), 25.20% in FY2022 (-5.54 pp) and 30.74% in FY2021 (+0.79 pp).
- The Q3 2026 figure stands as the highest quarterly Net Margin since Q4 2017.
- On a year-over-year basis, Net Margin increased in 1 of the last eight quarters, with an average year-over-year change of -5.35 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q3 2026, with a gain of 27.24 percentage points; the weakest was Q1 2026, with a drop of 31.83 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was 16.45% (Q2 2026), -18.92% (Q1 2026) and 11.83% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 19.55% |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 36.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.56% |
| Jun 30, 2026 | 16.45% |
| Mar 31, 2026 | -18.92% |
| Dec 31, 2025 | 11.83% |
| Sep 30, 2025 | 9.32% |
| Jun 30, 2025 | 17.80% |
| Mar 31, 2025 | 12.90% |
| Dec 31, 2024 | 16.71% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 21.44% |
| Mar 31, 2024 | 18.74% |
| Dec 31, 2023 | 23.00% |
| Sep 30, 2023 | 25.22% |
| Jun 30, 2023 | 23.24% |
| Mar 31, 2023 | 14.96% |
| Dec 31, 2022 | 16.04% |
| Sep 30, 2022 | 33.96% |
| Jun 30, 2022 | 26.50% |
| Mar 31, 2022 | 24.33% |
| Dec 31, 2021 | 32.44% |
API Access
Corcept Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();